Gerresheimer's quarterly sales recovery boosts shares (updated)

Gerresheimer AG

30/09/2026 09:01

Recasts with share move and Q2 revenue recovery in paragraphs 1-2, adds outlook comment in paragraph 3.
Sept 30 (Reuters) - Gerresheimer GXIG.DE reported a sequential recovery in its second-quarter revenue on Wednesday, sending its shares 8% higher in early trading, as demand for its drug delivery devices boosted sales.
The German drug-packaging maker reported preliminary revenue of €578 million ($656.09 million) for the second quarter, up from €474.9 million in first quarter of the financial year.
The company's half-year earnings before interest, taxes, depreciation and amortisation fell to €168 million from €210.4 million a year ago, but it reiterated that it expected the second half of the year to be stronger, after cutting its outlook in June.
($1 = 0.8810 euros)

(Reporting by Kira Britten and Danny Callaghan in Gdansk, editing by Milla Nissi-Prussak)
((Kira.Britten@thomsonreuters.com))